Payment & Shipping Terms:
HIV 1/2 Saliva Home Use Test
Arapid ,one step lateral flow immunoassay for the qualitative detection of HIV-1/2 antibodiesin human saliva For in vitrodiagnostic use
The Saliva HIV-1/2 Antibody Screen Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies to Human Immunodeficiency Virus type 1 and 2 (HIV-1/2) in human saliva. All positive specimens must be confirmed with Western Blot or other qualified EIA.
It has been shown that the acquired immunodeficiencysyndrome (AIDS) is caused by viruses which transmitted by sexual contact, transfusion, using contaminated blood products and sharing contaminated needles. HIV-1 and 2 viruses have been isolated from patients with AIDS and AIDS- related complex (ARC), high risk persons for AIDS. HIV-1/2 viruses deplete T helper cells, a subpopulation of T cells for body defense, thus causing AIDS patients susceptible to opportunistic infections and developing malignant tumors. The incidence of specific antibodies to HIV-1/2 is high in AIDS, ARC and persons with high risk for AIDS. The HIV-1/2 Antibody Saliva Rapid Screen Test was designed to detect antibodies to HIV- 1/2 in AIDS patients, ARC or high risk persons and identify any potential donors carrying these antibodies in specimens.The Saliva HIV-1/2 Antibody Screen Test is a chromatographic immunoassay for the detection of antibodies to HIV-1/2 in human saliva. HIV - 1/2 antibodies binding protein are precoated onto membrane as capture reagents i n the Test region (T). During the testing, the specimen is allowed to react with the colloidal gold reagents which have been labeled with HIV-1/2 specific antigens. Antibodies to HIV-1/2, if present, binds to antigens coated on colloidal gold, anda pinkcolored band will develop in the test region (T) on the membrane. Absence of this pink colored band in the test region (T) suggests a negative result. To serve as a procedural control, a pin kcolored band in the control region (C) will always appear regardless of the presence or absence of antibodies to HIV-1/2 in human saliva.
Contact Person: Ms. Anna Lee